Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) moved its Annual General Meeting to September 3 after the September 2 session was adjourned for lack of quorum. The reconvened meeting matters to investors as the stated next step in the company’s Shareholder proceedings at the offices of Meitar Law Offices in Ramat Gan.

Key Highlights

  • The September 2 shareholder meeting was adjourned because a quorum was not present.
  • The meeting is scheduled to reconvene on September 3 at 4:00 p.m. Israel time.
  • The reconvened meeting is scheduled at Meitar | Law Offices in Ramat Gan, Israel.

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) is scheduled to reconvene its annual general meeting of shareholders on September 3 after the September 2 session was adjourned for lack of quorum. The reconvened meeting is scheduled for the same time and place, at the offices of Meitar | Law Offices in Ramat Gan, Israel, the legal counsel’s location.

Shareholder Meeting Moves After Quorum Shortfall

The annual meeting’s September 2 session was adjourned for one day because the meeting lacked a quorum. The reconvened gathering was scheduled for the same time and location specified for the continuation of the meeting. Allen Baharaff, Galmed’s president and chief executive officer, signed on behalf of the company on September 2. The report was signed under the requirements of the Securities Exchange Act of 1934.

September 3 Reconvened Meeting Date

The one-day adjournment moved the annual meeting proceedings to September 3. The reconvened meeting was scheduled as the continuation of the shareholder gathering after the initial session lacked a quorum. The filing identifies the same Ramat Gan offices as the location for the meeting. The filing states that the meeting will be reconvened at that location.